View drug registration information details.


ItemsRegistration information
ID2094
No2094
Brand NameOMENIX 40
IngredientsOMEPRAZOLE SODIUM BP 44.6323 MG EQ. TO OMEPRAZOLE 40 MG
Dosage FormPOWDER FOR SOLUTION FOR INJECTION
Primary PackagingVIAL
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 1 VIAL + 1 AMPOULE OF 10 ML WATER FOR INJECTIONON
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsHEARTBURN, ANY SYMPTOMS OF GERD, EROSIVE ESOPHAGITIS, GASTRIC ULCER, DUODENAL ULCER AND REDUCTION OF RISK OF UPPER GI BLEEDING IN CRITICALLY ILL PATIENTS, PRIMARILY FOR THE TREATMENT OF ZOLLINGER-ELLISON SYNDROME
Contraindications
Side Effects
Unit Price
EDL NULL
DescriptionSTERILE, FREEZE-DRIED, WHITE TO OFF-WHITE POROUS CAKE OR POWDER FILLED IN COLORLESS GLASS VIAL. THE RECONSTITUTED SOLUTION IS CLEAR, COLORLESS AND HAVING NO VISIBLE RESIDUE AS UNDISSOLVED MATTER
Note
License OwnerPALAMY PHARMA CO., LTD
ManufacturerINCEPTA PHARMACEUTICALS LIMITED
CountryBANGLADESH
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No05 I 3321/09
FDD Registration Date23-NOV-2023
Expiry Date22-Nov-2026

Back to drug list